905562-91-6 Usage
Uses
Used in Pharmaceutical Industry:
(6-bromo-5-methoxy-2-pyridinyl)methanol is used as a key intermediate for the synthesis of potential drug candidates. Its role in creating biologically active compounds positions it as an essential component in the development of new medications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (6-bromo-5-methoxy-2-pyridinyl)methanol is utilized as an intermediate in the production of bioactive compounds. Its structural properties allow for its incorporation into a variety of molecules with potential therapeutic effects.
Used in Agrochemicals:
(6-bromo-5-methoxy-2-pyridinyl)methanol also finds application in the agrochemical industry, where it serves as an intermediate for the synthesis of compounds that can be used in the development of pesticides or other agricultural products. Its versatility in chemical reactions makes it a valuable asset in this field.
Check Digit Verification of cas no
The CAS Registry Mumber 905562-91-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,5,6 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 905562-91:
(8*9)+(7*0)+(6*5)+(5*5)+(4*6)+(3*2)+(2*9)+(1*1)=176
176 % 10 = 6
So 905562-91-6 is a valid CAS Registry Number.
905562-91-6Relevant academic research and scientific papers
BIARYL DERIVATIVES AS BROMODOMAIN INHIBITORS
-
, (2014/05/25)
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
CYCLIC AMINES AS BROMODOMAIN INHIBITORS
-
Paragraph 0545, (2014/05/25)
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
1-(PIPERIDIN-4-YL)-1H-INDOLE DERIVATIVE
-
Page/Page column 65, (2010/11/28)
The present invention provides a compound represented by the formula (1) or a pharmacologically acceptable salt thereof, or a hydrate thereof (provided that a compound in which all of R4a, R4b, and R4c are hydrogen atoms is excluded.): [wherein R1 represents a hydrogen atom, R2 represents a hydrogen atom, R3 represents the formula: wherein R4a, R4b, and R4c are the same as or different from each other and each represents a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, etc.]
